[Clinical study on a new cephalosporin: CGP 9000 (cefroxadine)]. / Ricerca clinica su una nuova cefalosporina: CGP 9000 (cefroxadina).

ABSTRACT

CGP 9000 (cefroxadine), a new cephalosporine derived from N-acyl-3-alkoxy-7-amino-3-cefem-4-carboxylic acid for exclusively oral use, has been experimented on 67 patients, 41 adults and 20 children. CGP 9000 appeared to possess good therapeutic activity, even in low doses its rapid absorption and moderate sero-protein bond are a guarantee of an immediate and almost total bioavailability.